These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21341465)

  • 1. [Metabolic syndrome and insulin resistance in patients with chronic hepatitis C].
    Baĭzhanova ZhZh; Ignatova TM; Nekrasova TP
    Ter Arkh; 2010; 82(10):51-6. PubMed ID: 21341465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic syndrome in patients with chronic hepatitis C genotype 1].
    Baĭzhanova ZhZh; Ignatova TM; Nekrasova TP; Abdurakhmanov DT
    Vestn Ross Akad Med Nauk; 2011; (1):3-7. PubMed ID: 21400720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of obesity and metabolic syndrome on chronic hepatitis C.
    Goossens N; Negro F
    Clin Liver Dis; 2014 Feb; 18(1):147-56. PubMed ID: 24274870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
    El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
    Hwang SJ; Lee SD
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical correlations of chronic hepatitis C, diabetes mellitus and steatohepatitis].
    Nemesánszky E
    Orv Hetil; 2011 May; 152(22):882-6. PubMed ID: 21565756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C.
    Lo Iacono O; Venezia G; Petta S; Mineo C; De Lisi S; Di Marco V; Rodolico V; Amato M; Ferraro D; Giordano C; Almasio PL; Craxí A
    Aliment Pharmacol Ther; 2007 May; 25(10):1181-91. PubMed ID: 17451564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.
    Hu KQ; Currie SL; Shen H; Cheung RC; Ho SB; Bini EJ; McCracken JD; Morgan T; Bräu N; Schmidt WN; Jeffers L; Wright TL;
    Dig Dis Sci; 2007 Feb; 52(2):570-8. PubMed ID: 17226072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
    Negro F
    J Viral Hepat; 2012 Jan; 19 Suppl 1():42-7. PubMed ID: 22233413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F; Clément S
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
    Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
    Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
    Mihm S
    Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of obesity on treatment of chronic hepatitis C.
    Charlton MR; Pockros PJ; Harrison SA
    Hepatology; 2006 Jun; 43(6):1177-86. PubMed ID: 16729327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study.
    Rosso C; Caviglia GP; Ciruolo M; Ciancio A; Younes R; Olivero A; Giordanino C; Troshina G; Abate ML; Rizzetto M; Pellicano R; Saracco GM; Bugianesi E; Smedile A
    Minerva Med; 2019 Oct; 110(5):401-409. PubMed ID: 31081312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C.
    Sanyal AJ
    Liver Int; 2011 Jan; 31 Suppl 1():23-8. PubMed ID: 21205134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.
    Hickman IJ; Powell EE; Prins JB; Clouston AD; Ash S; Purdie DM; Jonsson JR
    J Hepatol; 2003 Dec; 39(6):1042-8. PubMed ID: 14642624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.